    <SEC-DOCUMENT>0001140361-23-027029-index.html : 20230526
    <SEC-HEADER>0001140361-23-027029.hdr.sgml : 20230526
    <ACCEPTANCE-DATETIME>20230526170258
    ACCESSION NUMBER:		0001140361-23-027029
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20221231
    FILED AS OF DATE:		20230526
    DATE AS OF CHANGE:		20230526
    EFFECTIVENESS DATE:		20230526

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			NeuroBo Pharmaceuticals, Inc.
    		CENTRAL INDEX KEY:			0001638287
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		IRS NUMBER:				472389984
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-37809
    		FILM NUMBER:		23970087

    	BUSINESS ADDRESS:
    		STREET 1:		200 BERKELEY ST.
    		STREET 2:		FL 19
    		CITY:			BOSTON
    		STATE:			MA
    		ZIP:			02116
    		BUSINESS PHONE:		(857) 702-9600

    	MAIL ADDRESS:
    		STREET 1:		200 BERKELEY ST.
    		STREET 2:		FL 19
    		CITY:			BOSTON
    		STATE:			MA
    		ZIP:			02116

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
    		DATE OF NAME CHANGE:	20150331
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>ny20009150x3_ars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: ny20009150x3_ars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>